PHAS °Ë»ö°á°ú
611 °Ç (1/61 ÂÊ)
»ó¼¼Á¶°Ç 
 
ÆÄÀÏÁ¾·ù 
|
mp03322 / 0.ºÐ·ùÀÇ Áß¿äÇÑ °áÁ¡:±¤¹° Ç¥¸éÀÇ Æ¯¼ºÀ» °í·ÁÈ÷Áö ¾ÊÀ½ . Gaudin ÀÌ º¸Á¤½Ãµµ- ºÐ·ù¿¡¼´Â ±âÁØÀ» Ãß°¡ÇÏ¿© »ç¿ë : ÁÖÀ§ ¿øÀÚ³ª group¿¡ ÀÏÄ¡. 0. ±¤¹°¿¡ ºÐ·ù . °áÁ¤ Ç¥¸éÀÇ Æ¯¼ºÀ» Æ÷ÇÔÇϱâ À§Çؼ´Â (ºÐ¼âµÇ´Â µ¿¾È Çü¼ºµÈ)¿ÜºÎÀÇ ¿ªÇÐÀû Èû¿¡ ´ëÇÑ¿µÇâÀÌ ÀûÀº °áÁ¤µéÀ» ºÐ¼â ÅëÁ¦ÇÏ´Â ¹ýÄ¢À» ¼³¸íÇÏ´Â °ÍÀÌÇʼöÀû. . °áÁ¤µé¿¡ Ãæ°Ý, º®°³, ±¼°î, ¹Ì²ô·¯Áü°ú ´Ù¸¥ ¿©·¯¡¦ |
|
|
|
|
|
Àü±âȸ·Î ½ÇÇè ¹× ¼³°è ½ÇÇè 9ÁÖÂ÷ °á°úº¸°í¼ - ¹Ì¸®º¸±â¸¦ Âü°í ¹Ù¶ø´Ï´Ù. / <font color=red>º»¹®ÅؽºÆ®ºÎÁ· |
|
|
|
|
|
Àü±âȸ·Î ½ÇÇè ¹× ¼³°è ½ÇÇè 9ÁÖÂ÷ ¿¹ºñº¸°í¼ - ¹Ì¸®º¸±â¸¦ Âü°í ¹Ù¶ø´Ï´Ù. / <font color=red>º»¹®ÅؽºÆ®ºÎÁ· |
|
|
|
|
|
Àü±âȸ·Î ½ÇÇè ¹× ¼³°è ½ÇÇè 11ÁÖÂ÷ ¿¹ºñº¸°í¼ - ¹Ì¸®º¸±â¸¦ Âü°í ¹Ù¶ø´Ï´Ù. / <font color=red>º»¹®ÅؽºÆ®ºÎÁ· |
|
|
|
|
|
[ÀÚ¿¬°úÇÐ][ÀϹÝÈÇнÇÇè] Reversed Phase Chromatography[Å©·Î¸¶Åä ±×·¡ÇÇ]¿¡ ÀÇÇÑ »ö¼ÒºÐ¸® / Reversed Phase Chromatography¿¡ÀÇÇÑ »ö¼ÒºÐ¸® 1. Abstract ¨ç Introduction C18 cartridge¿Í »ö¼Ò ºÐ±¤±â¸¦ ÀÌ¿ëÇؼ »ö¼Ò¸¦ ºÐ¸®ÇÏ´Â ½ÇÇèÀ» Çغ¸°í ºÐÀÚÀÇ ±Ø¼º ¹× Å©·Î¸¶Åä±×·¡ÇÇÀÇ ¿ø¸®¸¦ ÀÌÇØÇÑ´Ù. ¨è ¿ø¸® ¢Í ºÐÀÚÀÇ ±Ø¼º ÀüÀÚ¿¡ ÀÇÇØ ÈÇÐ °áÇÕÀÌ ÀÌ·ç¾îÁø´Ù´Â °ÍÀÌ ÈÇÐÀÇ ¡¦ |
|
|
|
|
|
[ÀÚ¿¬°úÇÐ]È°ø»ý¸í ±âÃʽÇÇè - Binary Liquid-Vapor Phase[±â¾×ÆòÇü] / È°ø»ý¸í ±âÃʽÇÇè - Binary Liquid-Vapor Phase Â÷·Ê 1. Purpose (¸ñÀû) 2. Principle(¿ø¸®) 3. Materials and Reagent(Àç·á ¹× ½Ã¾à) 4. Procedure(½ÇÇè¹æ¹ý) 5. Observation(°íÂû) 6. Result(°á°ú) 1. Purpose(¸ñÀû) - ÀÌ ½ÇÇèÀÇ ¸ñÀûÀº 2¼ººÐ ¾×ü-±âüÀÇ ÆòÇü°è¸¦ °øºÎÇÏ´Â °ÍÀÌ´Ù. ÀÏÁ¤ ¾Ð·ÂÇÏÀÇ 2¼ººÐ ¿ë¡¦ |
|
|
|
|
|
À̻ۼձú²ýÇÑ¼Õ / 7 ÇÁ·Î±×·¥ ³»¿ë ‘ÀÌ»¼Õ, ±ú²ýÇÑ ¼Õ(¼Õ¾Ä±â Áýü½Ä ±³À°)±³À° ¸ñÇ¥ ±³À° ³»¿ë ¼Õ¾Ä±â ½ÇÅ ¹× ¹®Á¦Á¡ ¼Õ¾Ä±â Á߿伺 ÀÎ½Ä ¼Õ¾Ä±â Çൿ (µ¿¿µ»ó) 1830 Çൿ Áöħ È¿°ú Æò°¡ 7 ÇÁ·Î±×·¥ ³»¡¦ |
|
|
|
|
|
[ÀÚ¿¬°úÇÐ] [»ýÈÇнÇÇè] Áú¼Ò¿ø¿¡ µû¸¥ ¹Ì»ý¹°ÀÇ ¼ºÀå / Áú¼Ò¿ø¿¡ µû¸¥ ¹Ì»ý¹°ÀÇ ¼ºÀå -1- ¸ñ Â÷ ¡Û¼·Ð ½Ç Çè ¸ñ Àû4 ½Ç Çè ÀÌ ·Ð4~10 ¹Ì»ý¹°ÀÇ »ýÀ°°î¼±(growth curve)4~5 1. À¯µµ±â(lag phase, induction phase) 2. Áõ½Ä±â, ·Î±×´ë¼ö±â(logarithmic phase, exponential phase) 3. ¾ÈÁ¤±â, Á¤»ó±â(stationary phase, maximum phase) 4. »ç¸ê±â(death phase, phase of d¡¦ |
|
|
|
|
|
[ÀÇÇÐ][¹°¸®Ä¡·áÇÐ] Á¤»óº¸Çà°ú Æí¸¶ºñº¸Çà¿¡ °üÇØ / - ¸ñÂ÷ - ¥°. ¼·Ð 1. Á¤ÀÇ 1) Á¤»ó º¸Çà (Normal gait) 2) Æí¸¶ºñ º¸Çà (Hemiplegia gait) 2. ¿¬±¸ÀÇ ¸ñÀû ¥±. º»·Ð 1. Á¤»óº¸Çà (Normal gait) 1) Ư¡ (1) üÁß½É(Center of gravity : C.O.G.) (2) Pelvic rotation (3) ÀÔ°¢±â(stance phase) µ¿¾È kneeÀÇ motion (4) Ankle joint¿Í knee jointÀÇ °ü°è 2) º¸ÇàÁÖ±âÀÇ »ó (Ph¡¦ |
|
|
|
|
|
2. »ý½ÄÈ£¸£¸ó ¢º ½Ã»óÇϺÎÈ£¸£¸ó (1) GnRH (2) Endogenous opioid and effect on GnRH ¨ç ... / 2. »ý½ÄÈ£¸£¸ó ¢º ½Ã»óÇϺÎÈ£¸£¸ó (1) GnRH (2) Endogenous opioid and effect on GnRH ¨ç endorphin ¨è enkephalin ¨é dynorphin ¢º ³úÇϼöüȣ¸£¸ó (1) Àü¿±È£¸£¸ó ¨ç FSH and LH ; gonadotroph cell FSH - ³Æ÷¹ßÀ°°ú ¼ºÀå LH - ¹è¶õ, ȲüÇü¼º ¨è prolactin ; À¯Áó ÇÕ¼º ¡¦ |
|
|
|
|